|
Mylan to challenge court decision over generic asthma, COPD drug
Drug Store News … in the US District Court for the District of Delaware when the latter sought to market a generic version of Sunovion's Xopenex (levalbuterol hydrochloride) inhalation solution, a drug for asthma and chronic obstructive pulmonary disease. Mylan to fight $18M patent infringement ruling |
View full post on asthma – Google News